Blue Diamond Ventures Inc (BLDV)

[JPS02]

Despacito, that is a good question whose answer may be a good signal for BLDV shareholders. My interpretation of the information communicated in the 8/2/18 PR is the share exchange agreement, subject to final legal review, will be a purchase by BLDV of the remaining 75% equity in Cann10 NA, which is a private company, to make Cann10 NA a wholly owned subsidiary of BLDV.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142755146

I see it as a good signal since Cann10 Israel is willing to sell their equity in Cann10 NA and take BLDV shares in return as consideration. If the future operations of Cann10 NA generate revenues and net income returns to equity, there might be value (i.e. licensing of specific technologies and targeted therapies) going into BLDV as part of the share exchange agreement and thus BLDV shares may be worth more in the future.

In my opinion, including Cann10 NA in BLDV, a public entity, as a wholly owned subsidiary that can generate revenues and earnings may increase the pps and the value of the BLDV shares in the future if the share exchange agreement is successfully completed.

We will need to receive further details on the share exchange agreement from BLDV, subject to final legal review, in regards to how much Cann10 NA is valued at as part of the share exchange agreement, the type of BLDV shares that will be given as consideration (common or preferred shares) and the amount of consideration that will be given based on the valuation.

It will be interesting to see how this agreement gets completed subject to final legal review.

Thanks for sharing your insightful posts on this board and asking this interesting question.

Go BLDV!